RC28-E

· RemeGen Co., Ltd.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for RC28-E, covering 2022-01-10 to 2023-12-18. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of RC28-E Injection in Diabetic Macular Edema [Phase 2]